What is the purpose of launching the World Journal of Clinical Infectious Diseases?

Launching of the World Journal of Clinical Infectious Diseases(WJCID)could have been possible due to efforts of the publisher,members of the editorial board,all the authors and definitely our readers.I congratulate everyone for making it possible.Pathogenic organisms of various origin cause infectious diseases often resulting in symptomatic illness.WJCID is an open access peer reviewed journal that will be published bimonthly.WJCID will primarily emphasize on topics relevant to infections affecting human and animal health yet articles from other diseases and relevant issues will also be encouraged.WJCID welcomes articles from either basic or applied research in different disciplines like Epidemiology of communicable and non-communicable infections,Immunology and Genetics.WJCID covers topics like Host-Parasites interactions,Vector biology,development of advanced tools for diagnosis,genetic susceptibility to diseases,and disease prevention and vector control.WJCID will work as an important resource of basic and applied research in the field of infections.It is widely recommended that clinical implementations of basic and applied research be encouraged for the benefit to each stream.So again I welcome everyone and assure that WJCID will be a great platform where you can feel free to share your valuable results,discuss new hypothesis and research problems and update yourself with the most recent advancements made in the field of infections.

Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective

Visceral leishmaniasis(VL)is a serious parasitic disease causing considerable mortality and major disability in the Indian subcontinent.It is most neglected tropical disease,particularly in terms of new drug development for the lack of financial returns.An elimination campaign has been running in India since 2005 that aim to reduce the incidence of VL to below 1 per 10,000 people at sub-district level.One of the major components in this endeavor is reducing transmission through early case detection followed by complete treatment.Substantial progress has been made during the recent years in the area of VL treatment,and the VL elimination initiatives have already saved many lives by deploying them effectively in the endemic areas.However,many challenges remain to be overcome including availability of drugs,cost of treatment(drugs and hospitalization),efficacy,adverse effects,and growing parasite resistance.Therefore,better emphasis on implementation research is urgently needed to determine how best to deliver existing interventions with available anti-leishmanial drugs.It is essential that the new treatment options become truly accessible,not simply available in endemic areas so that they may promote healing and save lives.In this review,we highlight the recent advancement and challenges in current treatment options for VL in disease endemic area,and discuss the possible strategies to improve the therapeutic outcome.